Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperpolarized 129Xe MRI in COPD
NCT01697332Phase 2Terminated
- Sponsor
- Brigham and Women's Hospital
- Start
- Jan 2013
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hyperpolarized xenon gas in chronic obstructive pulmonary disease (COPD), sponsored by Brigham and Women's Hospital. Started Jan 2013; status: terminated.
02
Drugs
hyperpolarized xenon gas
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01697332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01697332.